Drug Type Small molecule drug |
Synonyms TCR 1672, TCR-1672, TCR1672 |
Target |
Action antagonists |
Mechanism P2X3 receptor antagonists(P2X purinoceptor 3 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Refractory chronic cough | Phase 2 | - | 01 Feb 2024 |





